ReviewImmunology2019
Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapy.
Ee Lyn Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ReviewImmunology2019
Ee Lyn Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.